- Home
- GALT vs CCG Comparison
GALT vs CCG Comparison
Compare GALT & CCG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GALT
- CCG
- Stock Information
- Founded
- GALT 2000
- CCG 2014
- Country
- GALT United States
- CCG China
- Employees
- GALT N/A
- CCG N/A
- Industry
- GALT Biotechnology: Pharmaceutical Preparations
- CCG
- Sector
- GALT Health Care
- CCG
- Exchange
- GALT Nasdaq
- CCG Nasdaq
- Market Cap
- GALT 83.5M
- CCG 68.6M
- IPO Year
- GALT N/A
- CCG N/A
- Fundamental
- Price
- GALT $1.31
- CCG $0.82
- Analyst Decision
- GALT Hold
- CCG
- Analyst Count
- GALT 1
- CCG 0
- Target Price
- GALT N/A
- CCG N/A
- AVG Volume (30 Days)
- GALT 176.3K
- CCG 170.1K
- Earning Date
- GALT 05-15-2025
- CCG 06-06-2025
- Dividend Yield
- GALT N/A
- CCG N/A
- EPS Growth
- GALT N/A
- CCG N/A
- EPS
- GALT N/A
- CCG N/A
- Revenue
- GALT N/A
- CCG $475,831,129.00
- Revenue This Year
- GALT N/A
- CCG N/A
- Revenue Next Year
- GALT N/A
- CCG $7.06
- P/E Ratio
- GALT N/A
- CCG N/A
- Revenue Growth
- GALT N/A
- CCG 5.20
- 52 Week Low
- GALT $0.73
- CCG $0.56
- 52 Week High
- GALT $3.17
- CCG $1.57
- Technical
- Relative Strength Index (RSI)
- GALT 48.59
- CCG 46.18
- Support Level
- GALT $1.22
- CCG $0.78
- Resistance Level
- GALT $1.36
- CCG $0.84
- Average True Range (ATR)
- GALT 0.10
- CCG 0.03
- MACD
- GALT -0.00
- CCG 0.00
- Stochastic Oscillator
- GALT 29.41
- CCG 48.20
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
About CCG Cheche Group Inc.
Cheche Group Inc is engaged in the operation of providing insurance transaction services, Software-as-a-Service (SaaS) services and other services in China.. It is China's independent technology-empowered platform for auto insurance transaction services by digital auto insurance transaction premiums and insurance technology companies. The company has reshaped the traditional auto insurance distribution and services value chain to create a digital platform by improving operational efficiencies, reducing transaction costs, and expanding distribution channels. Its business scope ranges from digital insurance transactions, SaaS platforms for insurance intermediaries, AI-driven insurance pricing and underwriting services, auto insurance services for new energy vehicle (NEV) manufacturers, etc.